346 H.N. Kim et al.
In this study, the effects of three different EDCs (17-beta estradiol, nonylphenol
and bisphenol A) were analyzed by measuring the expression levels of specific
biomarkers within Japanese Medaka. The biomarkers used were the genes encoding
for vitellogenin, choriogenin L, cytochrome P450 1A and heat shock protein 70.
Each biomarker differed in its expression pattern depending on the chemical being
tested, and these differences were used to explain the characteristic toxicity
signature of each compound. All three of the chemicals tested are known EDCs that
have estrogenic effects within male Medaka (Yamaguchi et al. 2005). Therefore,
the Vtg and Chg-L genes were selected to investigate and compare the estrogenic
activities of each chemical. The results of this study clearly show that E
2
causes the
strongest estrogenic effect among the compounds tested, while NP and BPA were
similar in their estrogenic activities. Interestingly, exposure to E
2
leads to decreased
CYP1A and HSP 70 expression, a result not seen with NP or BPA. CYP 1A is
specifically responsive to NP, suggesting that NP causes some form of cellular
toxicity that is modulated by CYP 1A. Similarly, HSP 70 genes were induced after
exposure to NP and BPA, indicating that these compounds have some other effects
on the liver cells not only just an estrogenic effect.
In summary, through real time PCR, the expression levels of five genes were
quantified and it was found that each biomarker was differentially expressed
according to the exposure time and concentration of the EDCs (E
2
, NP and BPA)
tested. From these results, the response characteristics of male Japanese Medaka
were successfully investigated and analyzed.
Acknowledgements Authors are grateful to the Laboratory of Freshwater Fish Stocks within
the Bioscience Center, Nagoya University (Chikusa, Nagoya, Japan) for their support in the prepa-
ration of the Japanese Medaka stocks. This work has been financially supported by the ECO
project of the Korean Ministry of Environment, and authors appreciate the support.
References
Birnbaum L.S. and Fenton S.E. (2003), Cancer and developmental exposure to endocrine disrup-
tors, Environ. Health Persp., 111, 389–394.
Bustin S.A. (2002), Absolute quantification of mRNA using real-time reverse transcription
polymerase chain reaction assays, J. Mol. Endocrinol., 25, 169–193.
Flouriot G., Pakdel F., and Valotaire Y. (1996), Transcriptional and post-transcriptional regulation
of rainbow trout estrogen receptor and vitellogenin gene expression, Mol. Cellular Endocrinol.,
124, 173–183.
Gallicchio L., Visvanathan K., Miller S.R., Babus J., Lewis L.M., Zacur H., et al. (2005),
Body mass, estrogen levels, and hot flashes in midlife women, Am. J. Obstet. Gynecol.,
193, 1353–1360.
Janosek J., Hilscherova K., Blaha L., and Holoubek I. (2006), Environmental xenobiotics and
nuclear receptors-interactions, effects and in vitro assessment. Toxicol. In Vitro, 20, 18–37.
Lee C., Na J.G., Lee K.C., and Park K. (2002), Choriogenin mRNA induction in male medaka,
Oryzias latipes as a biomarker of endocrine disruption, Aquat. Toxicol., 61, 233–241.
Lim E.H., Ding J.L., and Lam T.J. (1991), Estradiol-induced vitellogenin gene expression in a
teleost fish, Oreochromis aureus. Gen. Comp. Endocrin., 82, 206–214.